news 
The recent Ripple lawsuit settlement has sparked a surge of interest in the potential for corporate entities to include XRP in their treasury strategies. According to recent SEC filings, several companies have disclosed adding XRP to their balance sheets, mirroring a trend seen with Ethereum treasury holdings.
In a significant development, Quantum Biopharma and Worksport Ltd. have announced the addition of XRP to their portfolios, marking a strategic decision that aligns with their growing interest in cryptocurrency assets. This move is expected to be replicated by other companies as Ripple’s legal issues are now behind it.
Ripple’s treasury strategy has gained renewed attention following the settlement. The recent surge in institutional investment and Ethereum’s treasury growth have paved the way for this shift towards XRP adoption.
As per Bill Morgan, Pro-XRP lawyer, these filings represent just the beginning of a larger trend. “Corporate interest in XRP is growing, and this could trigger a broader trend of companies adding XRP to their balance sheets,” he noted.
In contrast, Ripple’s treasury strategy marks a departure from the traditional financial instruments like bonds, stocks, or commodities that corporations typically hold as part of their treasury strategies. The addition of XRP to corporate treasuries highlights the increasing institutional acceptance and growing demand for cryptocurrency exposure.
Moreover, with Ripple’s legal woes now behind it, more companies are expected to follow suit and integrate XRP into their financial strategies. This is reminiscent of the trend seen in Ethereum, where large institutional players have been building digital asset treasuries in recent years.
It remains to be seen whether this development will translate to a larger impact on the cryptocurrency market as institutions seek diversified portfolios that include exposure to XRP.
Source: coincentral.com
